The emergence of SARS-CoV-2 variants highlighted the need to better
understand adaptive immune responses to this virus. It is important to address
whether also CD4+ and CD8+ T cell responses are affected, because of the role
they play in disease resolution and modulation of COVID-19 disease severity.
Here we performed a comprehensive analysis of SARS-CoV-2-specific CD4+ and CD8+
T cell responses from COVID-19 convalescent subjects recognizing the ancestral
strain, compared to variant lineages B.1.1.7, B.1.351, P.1, and CAL.20C as well
as recipients of the Moderna (mRNA-1273) or Pfizer/BioNTech (BNT162b2) COVID-19
vaccines. Similarly, we demonstrate that the sequences of the vast majority of
SARS-CoV-2 T cell epitopes are not affected by the mutations found in the
variants analyzed. Overall, the results demonstrate that CD4+ and CD8+ T cell
responses in convalescent COVID-19 subjects or COVID-19 mRNA vaccinees are not
substantially affected by mutations found in the SARS-CoV-2 variants.